Added to YB: 2016-01-06
Pitch date: 2016-01-06
AVXL:US [bearish]
Anavex Life Sciences Corp.
-24.85%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Anavex Life Sciences Corp. operates as a biopharmaceutical company. It engages in developing innovative treatments for Alzheimer’s disease, Parkinson’s disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, pain, and various types of cancer .
Market Cap
$359.6M
Pitch Price
$3.30
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
-8.39
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
ANAVEX LIFE SCIENCES CORP COM AVXL:US
A summary for this pitch has not been created yet.
Read full article (0 min)